Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Casemanagement dementie al verzekerde zorg vanaf ‘niet pluis’-fase
mei 2024 | Dementie